Workflow
Penumbra (PEN) Beats Q4 Earnings and Revenue Estimates
PENPenumbra(PEN) ZACKS·2025-02-18 23:20

Group 1 - Penumbra reported quarterly earnings of 0.97pershare,exceedingtheZacksConsensusEstimateof0.97 per share, exceeding the Zacks Consensus Estimate of 0.91 per share, and up from 0.76pershareayearago,representinganearningssurpriseof6.590.76 per share a year ago, representing an earnings surprise of 6.59% [1] - The company achieved revenues of 315.52 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 1.07%, and an increase from 284.68millionyear−over−year[2]−Overthelastfourquarters,PenumbrahassurpassedconsensusEPSestimatesthreetimesandtoppedconsensusrevenueestimatesfourtimes[2]Group2−Penumbrashareshaveincreasedapproximately13.1284.68 million year-over-year [2] - Over the last four quarters, Penumbra has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2] Group 2 - Penumbra shares have increased approximately 13.1% since the beginning of the year, outperforming the S&P 500's gain of 4% [3] - The current consensus EPS estimate for the upcoming quarter is 0.82 on revenues of 318.45million,andforthecurrentfiscalyear,itis318.45 million, and for the current fiscal year, it is 3.86 on revenues of $1.37 billion [7] - The Medical - Instruments industry, to which Penumbra belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook [8]